Skip to main content
  • Subscribe
  • Register
  • Sign in
  • Membership
  • Events
  • Knowledge Center
  • About
  • Subscribe
  • Register
  • Sign in
  • Add
    • taub.jpg
    Steve Taub
    Hedgies Eye Another IPO
    Several prominent life sciences hedge funds hope to cash in on the second biopharma company in the past week to file plans to go public.
    Steve Taub September 4, 2024
    LABOARATORY FLASK WITH A DOLLAR SIGN, 3D ILLUSTATION

    ILLUSTRATION OF A DOLLAR IN TEST TUBE

    Credit: rikirennes/Getty Images

    Contact Info

    New York
    1270 Avenue of the Americas, Suite 1100
    New York, NY 10020
    P: +1 212 224 3300

    London
    4 Bouverie Street
    London EC4Y 8AX
    P: +44 207 779 8888

    Hong Kong
    Unit 2488, 24/F
    Lee Garden One,
    33 Hysan Avenue
    Causeway Bay, Hong Kong
    P: +852 2912 8001

    Corporate

    About Us

    Leadership Team

    Careers

    II Press Room

    Digital

    Masthead

    Thought Leadership

    Display Advertising

    Reprints

    FAQs

    Events

    Events Calendar

    Memberships

    Subscription

    Subscribe to Premium

    Register

    Register for Free Account

    Newsletters

    Sign up for II newsletters

    © 2025 Institutional Investor LLC. All material subject to strictly enforced copyright laws. Please read our Terms & Conditions, Modern Slavery Act Transparency Statement, Accessibility Statement and Privacy Policy before using the site.

    LinkedIn
    X
    Bluesky

    4.15.05 build:2026-02-06   Login